Resource Library

The Growth of Qui Tam Litigation in Healthcare

The surge in qui tam litigation — lawsuits brought by private individuals on behalf of the government — represents one of the most important shifts in healthcare law. We’ve witnessed how these cases have reshaped accountability, returning billions to taxpayers while empowering insiders to act against fraud. Before the 1986 amendments to the False Claims […]

The Growth of Qui Tam Litigation in Healthcare Read More »

HIPAA & Whistleblowing

For whistleblowers in healthcare, few topics cause more confusion or concern than HIPAA — the Health Insurance Portability and Accountability Act. While HIPAA protects patient privacy, it also includes specific exceptions that allow whistleblowers to report fraud and abuse lawfully. Under HIPAA, healthcare workers are generally prohibited from disclosing protected health information (PHI). However, 45

HIPAA & Whistleblowing Read More »

Evolution of Retaliation Protections for Employees

At Barrett Johnston, we regularly advise whistleblowers on navigating one of the biggest risks to reporting fraud: retaliation. The evolution of retaliation protections in U.S. law tells the story of how society gradually learned to value — and legally defend — those who speak out. Early federal protections were minimal. It wasn’t until the Civil

Evolution of Retaliation Protections for Employees Read More »

DaVita Healthcare Settlement (2014)

The DaVita Healthcare Partners settlement of 2014 was a defining moment in the fight against illegal financial relationships in healthcare. It is a key case in demonstrating how whistleblowers can expose physician kickback schemes hidden behind legitimate-looking business deals. DaVita, one of the largest kidney care/dialysis providers in the U.S., agreed to pay $389 million

DaVita Healthcare Settlement (2014) Read More »

Affordable Care Act Fraud Provisions (2010)

Beyond expanding coverage, the Affordable Care Act (ACA) reshaped healthcare fraud enforcement. At Barrett Johnston, we see its fraud provisions as some of the most impactful reforms in modern healthcare law. The ACA strengthened the False Claims Act (FCA) and the Anti-Kickback Statute (AKS), clarifying that any claim tainted by a kickback is automatically a

Affordable Care Act Fraud Provisions (2010) Read More »

Expansion of Anti-Kickback Statute Enforcement

The Anti-Kickback Statute (AKS) has long been a cornerstone of healthcare fraud prevention — but it wasn’t always enforced with the rigor we see today. The expansion of the AKS over time reflects a growing national commitment to ethical healthcare practices. Originally enacted in 1972, the AKS made it illegal to knowingly offer or receive

Expansion of Anti-Kickback Statute Enforcement Read More »

Abbott Laboratories $1.5 Billion Settlement (2012)

In 2012, Abbott Laboratories agreed to pay $1.5 billion to resolve criminal and civil allegations related to the unlawful promotion of its anti-seizure drug, Depakote. For Barrett Johnston, this case stands as a powerful example of how whistleblowers can hold even the largest pharmaceutical companies accountable for deceptive practices. Abbott was accused of marketing Depakote

Abbott Laboratories $1.5 Billion Settlement (2012) Read More »

Notable Supreme Court Rulings on FCA Interpretation

We often remind clients that the False Claims Act (FCA) — though written during the Civil War — is continually shaped by modern court decisions. Over the decades, several U.S. Supreme Court rulings have refined how the FCA is interpreted, influencing everything from what counts as a “false claim” to how whistleblowers can recover damages.

Notable Supreme Court Rulings on FCA Interpretation Read More »